Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Extending HIV Care Beyond the Rural Health Center
Brief Summary: The objective of this application is to develop and assess a system which uses non-clinician extenders to provide selected aspects of HIV care in rural western Kenya. The plan is to train persons living with HIV/AIDS (PLWAs) to undertake this role as Community Care Coordinators. Our central hypothesis, is that PLWAs can be effective members of the health care team and that their involvement in community-based HIV care will facilitate patient access to services and improve outcomes. As such our two specific aims are: 1) To develop a sustainable system to extend HIV care into the community and to train the individuals necessary to support such a system (Community Care Coordinators). 2) To determine the impact of Community Care Coordinators on patient adherence (to drugs and to clinic visits), clinical outcomes (i.e. viral load responses \[an individuals level of circulating HIV virus\], inter-current opportunistic infections, hospitalization, drop out from the program, change to second line therapy and mortality) and patient perception of stigma. This study will provide invaluable data on the use of non-clinician care extenders for providing HIV care in resource poor settings. As such, knowledge gained from this study will assist in developing a model for non-clinician centered HIV care systems elsewhere in sub-Saharan Africa.


Options:
A: Arm Label: I; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: II; Type: EXPERIMENTAL; Interventions: Other: Home visit by community care coordinators | Intervention Type: OTHER; Name: Home visit by community care coordinators; Assigned to Arm(s): II
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Monitoring by an HIV-trained medical doctor, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Monitoring by an HIV-trained primary care nurse, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine | Intervention Type: BEHAVIORAL; Name: Monitoring by an HIV-trained medical doctor; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Monitoring by an HIV-trained primary care nurse; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Lamivudine; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Stavudine; Assigned to Arm(s): A, B
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Atazanavir, Drug: Didanosine, Drug: Efavirenz, Drug: Emtricitabine/Tenofovir disoproxil fumarate, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine, Drug: Tenofovir disoproxil fumarate, Drug: Zidovudine/Lamivudine | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Atazanavir, Drug: Didanosine, Drug: Efavirenz, Drug: Emtricitabine/Tenofovir disoproxil fumarate, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Stavudine, Drug: Tenofovir disoproxil fumarate, Drug: Zidovudine/Lamivudine | Intervention Type: DRUG; Name: Atazanavir; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Didanosine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Emtricitabine/Tenofovir disoproxil fumarate; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Lamivudine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Stavudine; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Tenofovir disoproxil fumarate; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Zidovudine/Lamivudine; Assigned to Arm(s): 1, 2
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Health Workers Intervention | Arm Label: B; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Health Workers and Mobile Phone Intervention | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer Health Workers Intervention; Assigned to Arm(s): A | Intervention Type: BEHAVIORAL; Name: Peer Health Workers and Mobile Phone Intervention; Assigned to Arm(s): B

Answer: A